At a glance
ClinicalIndex Comparison RecordN/ACompleted· 343 enrolled
Drug / intervention
Omnipod 5 Automated Glucose Control Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes
In Brief
A clinical study evaluating Omnipod 5 Automated Glucose Control System for Type2 Diabetes. Completed, enrolled 343 participants across 21 sites.
Detailed Summary
This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType2 Diabetes
CountriesUnited States
CollaboratorsJaeb Center for Health Research
Timeline
N/ACompletedFinished
202420252026
Enrollment StartApr 2023
First PostedApr 2023
Primary CompletionMar 2024
TodayJul 2026
First PostedApr 18, 2023
Enrollment StartApr 11, 2023
Primary CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.2 years ago
Interventions
Omnipod 5 Automated Glucose Control Systemdevice
The Omnipod Horizon™ Automated Glucose Control System will provide automated insulin delivery